First results from the European project “HG NCoV19 test” for a rapid diagnostic system

The researchers involved in the “HG nCoV19 test” project, selected for funding as part of the special Horizon 2020 call launched in January to address Coronavirus, have obtained approval for the placing on the market of a new rapid diagnostic system for the COVID-19. By bringing together public and private organizations from Ireland, Italy, the UK and China, the “HG nCoV19 test” project developed a new portable diagnostic system to detect viral infection that provides accurate and reliable results in 30 minutes. HiberGene, the Irish company that coordinates the project, announced on May 20 that it had obtained the CE mark required for medical devices to be placed on the market. The total EU contribution to the project is € 930,000. The consortium partners, HiberGene in Dublin, IRCCS Policlinico San Martino Hospital in Genoa, Queens University in Belfast and Medcaptain Medical Technologies in China, will continue to work together to evaluate potential additional uses of the test. More information: SOURCE (First)